tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

LUMO Stock Latest News

Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
Press ReleasesLumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
7d ago
LUMO
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
PremiumPress Releases
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
1M ago
LUMO
Lumos Pharma receives notice of allowance from USPTO for LUM-201 patent
PremiumThe Fly
Lumos Pharma receives notice of allowance from USPTO for LUM-201 patent
1M ago
LUMO
Lumos Pharma reports Q4 EPS ($1.17), consensus ($1.15)
PremiumThe Fly
Lumos Pharma reports Q4 EPS ($1.17), consensus ($1.15)
2M ago
LUMO
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
PremiumPress Releases
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
2M ago
LUMO
Lumos Pharma, Inc. (LUMO) Q4 Earnings Cheat Sheet
PremiumPre-EarningsLumos Pharma, Inc. (LUMO) Q4 Earnings Cheat Sheet
2M ago
LUMO
Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024
PremiumPress Releases
Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024
2M ago
LUMO
Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
PremiumPress Releases
Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
3M ago
LUMO
Lumos Pharma promotes Pisit Pitukcheewanont, MD to CMO, effective January 1
PremiumThe Fly
Lumos Pharma promotes Pisit Pitukcheewanont, MD to CMO, effective January 1
4M ago
LUMO
Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical Officer
PremiumPress Releases
Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical Officer
4M ago
LUMO
Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency
PremiumPress Releases
Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency
5M ago
LUMO
Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November
PremiumPress Releases
Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November
5M ago
LUMO
Lumos Pharma announces OraGrowtH210, OraGrowtH212 meet all endpoints
PremiumThe FlyLumos Pharma announces OraGrowtH210, OraGrowtH212 meet all endpoints
6M ago
LUMO
Lumos Pharma reports Q3 EPS ($1.04), consensus ($1.15)
PremiumThe Fly
Lumos Pharma reports Q3 EPS ($1.04), consensus ($1.15)
6M ago
LUMO
Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates
PremiumPress Releases
Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates
6M ago
LUMO
Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints
PremiumPress Releases
Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints
6M ago
LUMO
Lumos Pharma announces new data, analysis of patient from OraGrowtH212 trial
PremiumThe Fly
Lumos Pharma announces new data, analysis of patient from OraGrowtH212 trial
7M ago
LUMO
Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting
PremiumPress Releases
Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting
7M ago
LUMO
Lumos Pharma Announced Abstract Accepted for Oral Presentation at the European Society for Paediatric Endocrinology Annual Meeting
PremiumPress Releases
Lumos Pharma Announced Abstract Accepted for Oral Presentation at the European Society for Paediatric Endocrinology Annual Meeting
7M ago
LUMO
Lumos Pharma Announces Participation in Investor Conferences in September
PremiumPress ReleasesLumos Pharma Announces Participation in Investor Conferences in September
8M ago
LUMO
Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape
PremiumPress Releases
Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape
8M ago
LUMO
Lumos Pharma price target lowered to $10 from $14 at Cantor Fitzgerald
PremiumThe Fly
Lumos Pharma price target lowered to $10 from $14 at Cantor Fitzgerald
8M ago
LUMO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >